| Product Name | MF | CAS | Details |
|---|
| CDD-1845 | C34H31N5O2 | 2894104-50-6 | Details |
| Syk-IN-8 | C23H26N10 | 2568963-01-7 | Details |
| IIIM-8 | C14H17NO4 | 1128053-62-2 | Details |
| NWP-0476 | C47H53ClN8O8S | 2290611-26-4 | Details |
| DCLK1-IN-2 | C26H32N8O3S | 2978517-43-8 | Details |
| ER degrader 6 | 2922929-62-0 | Details |
| CBP/p300-IN-21 | C19H16NO4.Cl | 1065581-69-2 | Details |
| SP-2-225 | C28H34N2O3 | 2364448-93-9 | Details |
| Antibacterial agent 154 | 2163048-45-9 | Details |
| FD1024 | C21H20F2N4O2S | 1422456-47-0 | Details |
| CDD-1733 | 2894104-33-5 | Details |
| CDD-1819 | 2894104-40-4 | Details |
| ER degrader 7 | 2922929-63-1 | Details |
| HL23 | C44H44N2O7 | 1448355-15-4 | Details |
| AMPA receptor modulator-5 | C20H12F4N6 | 2034182-22-2 | Details |
| TMV-IN-5 | C22H23N3S | 1207318-92-0 | Details |
| Y18501 | 2410627-32-4 | Details |
| Anticancer agent 127 | C26H37FN4O6S | 2410953-19-2 | Details |
| IACS-52825 | C16H13F7N4O2 | 2640376-72-1 | Details |
| SARS-CoV-2-IN-43 | C16H12O3 | 31356-11-3 | Details |
| Homouridine | C10H14N2O6 | 30685-57-5 | Details |
| Antitumor agent-114 | 2757762-91-5 | Details |
| BI 7446 | C20H22FN9O10P2S2 | 2767011-00-5 | Details |
| Anticancer agent 128 | 2941243-62-3 | Details |
| Antitrypanosomal agent 14 | C14H23N3OS | 1447933-37-0 | Details |
| HIV-1 protease-IN-9 | 2925381-27-5 | Details |
| RSV L-protein-IN-3 | 868860-35-9 | Details |
| Antitumor agent-104 | C31H33FN6O3 | 2245272-16-4 | Details |
| MK-8768 | C21H22F3N5O2 | 1432729-22-0 | Details |
| 6-Iodoamiloride | C6H8IN7O | 60398-23-4 | Details |
| STAT3-IN-18 | C18H24Cl2N2O6Pt | 2668267-41-0 | Details |
| Topoisomerase II inhibitor 15 | 451516-79-3 | Details |
| Tuberculosis inhibitor 7 | C21H18FN3O2S | 121041-20-1 | Details |
| CT1113 | C25H29N5O2S | 2523435-18-7 | Details |
| DPP | C36H40Cl2N2O10Pt | 2668267-47-6 | Details |
| RUNX-IN-1 | C71H88Cl2N24O11 | 2177285-35-5 | Details |
| Antifungal agent 66 | 1613152-33-2 | Details |
| M867 | C27H43N7O6 | 680999-39-7 | Details |
| Sirt1/2-IN-2 | C18H14N4O3S2 | 670267-73-9 | Details |
| 1-Isopropyltryptophan | 1219485-46-7 | Details |
| AMPA receptor modulator-6 | C24H36N2O4S2 | 516491-33-1 | Details |
| BT424 | C22H15BCl2N2O2 | 2755180-37-9 | Details |
| RSV L-protein-IN-2 | C32H36N4O5 | 774130-99-3 | Details |
| YXG-158 | C30H36FN3O | 2952994-34-0 | Details |
| 3′-Acetate-ATP | C12H18N5O14P3 | 90290-58-7 | Details |
| Anticancer agent 121 | 2924532-47-6 | Details |
| G43-C3-TEG | 2702262-15-3 | Details |
| PD-1/PD-L1-IN-34 | 2924403-17-6 | Details |
| PI3Kδ-IN-13 | 1686137-02-9 | Details |
| WLB-89462 | C21H29N5O3 | 2849471-75-4 | Details |
| Tuberculosis inhibitor 6 | C21H19N3O2S | 121041-08-5 | Details |
| DUB-IN-7 | C17H19N5O | 2894064-79-8 | Details |
| Leucettinib-92 | C21H22N4OS | 2732859-57-1 | Details |
| 22-(4′-py)-JA | 1178895-15-2 | Details |
| RUNX-IN-2 | C71H88Cl2N24O11 | 2893777-88-1 | Details |
| CFTR corrector 12 | C19H21ClN4O2S2 | 958941-60-1 | Details |
| Anticancer agent 122 | C18H15ClN2O2S | 2924532-50-1 | Details |
| DQP-26 | C28H21Cl2N3O4 | 1449373-99-2 | Details |
| GPR119 agonist 2 | C23H24FN5O4S2 | 1384951-03-4 | Details |
| PPARγ agonist 8 | C19H12F4O2S | 1049800-41-0 | Details |
| Tuberculosis inhibitor 8 | C21H19FN4O | 141353-07-3 | Details |
| SDH-IN-3 | C15H11F2N3OS | 2805297-11-2 | Details |
| CDK9-IN-23 | C22H25ClN4O3 | 2761572-96-5 | Details |
| PRMT5-IN-28 | C18H19ClN4O5 | 2242753-66-6 | Details |
| ATR-IN-29 | C19H22N8O | 2761193-67-1 | Details |
| Bcl-2-IN-11 | C45H49ClFN7O8S | 2760536-88-5 | Details |
| BTK-IN-25 | 2562351-92-0 | Details |
| PROTAC IRAK4 degrader-8 | C43H50ClF2N11O5 | 2911615-06-8 | Details |
| RSV L-protein-IN-5 | 851658-28-1 | Details |
| Estrogen receptor modulator 8 | 2170766-56-8 | Details |
| THR-β modulator-1 | 2770373-00-5 | Details |
| FEN1-IN-6 | C12H8N2O5S2 | 824983-84-8 | Details |
| ATR-IN-22 | C25H31N7O | 2905312-07-2 | Details |
| AXL-IN-15 | 1954722-22-5 | Details |
| CDK4-IN-2 | 2380320-68-1 | Details |
| DNA-PK-IN-10 | C25H28N6O2 | 2919315-89-0 | Details |
| PCSK9-IN-15 | 2455423-94-4 | Details |
| WM-586 | C20H20F3N5O3S | 2894832-05-2 | Details |
| Hedgehog IN-2 | 1126365-74-9 | Details |
| JAK1-IN-10 | 2416858-88-1 | Details |
| JAK-IN-27 | C20H21F2N7O | 2673176-36-6 | Details |
| TRPC3/6-IN-2 | 2387893-55-0 | Details |
| TRV-1387 | C23H25F3N4O2 | 1569645-63-1 | Details |
| KRAS G12D modulator-1 | 2883034-05-5 | Details |
| mTOR inhibitor-11 | C21H26N6O2 | 3033409-32-1 | Details |
| ROCK-IN-7 | C17H17N3O2S | 2376635-95-7 | Details |
| JAK1-IN-11 | C26H36N6O4S | 2427608-43-1 | Details |
| MOR agonist-1 | C22H26ClFN2O2 | 2305781-14-8 | Details |
| HDAC8-IN-4 | C17H14N2O2S2 | 1600528-05-9 | Details |
| RET-IN-24 | C27H26F2N8O | 2583767-68-2 | Details |
| DQn-1 | C16H14ClN5O2 | 57343-54-1 | Details |
| Estrogen receptor modulator 7 | 2639168-13-9 | Details |
| Immuno modulator-1 | C32H31FN6O4 | 2757469-20-6 | Details |
| MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | C63H91N9O16 | 1609108-96-4 | Details |
| KRAS degrader-1 | C55H57Br2ClFIN8O7 | 2795275-59-9 | Details |
| CDK4/6-IN-17 | C27H28F4N8 | 2035069-96-4 | Details |
| Orexin receptor modulator-1 | 2125735-57-9 | Details |
| PROTAC KRAS G12C degrader-3 | C63H75ClN14O6 | 2768099-51-8 | Details |
| USP7-IN-12 | C29H28ClFN4O2S | 2763698-01-5 | Details |
| GLX481304 | C23H29N7O | 701224-63-7 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 | ||||